Gapping down
News:
- NVCR -41.2% (Provides update on phase 3 ENGOT-ov50 / GOG-3029 / INNOVATE-3 trial evaluating tumor treating fields therapy in platinum-resistant ovarian cancer)
- ARCB -2% (shipping guidance update)
- ALNY -1.9% (to appeal Delaware Court order construing certain claim terms in two patents)
- IMGN -0.9% (announces collaboration with Takeda (TAK) to develop and commercialize ELAHERE in Japan)
- ATLX -0.8% (files for $75 mln mixed securities shelf offering)
Analyst comments:
- UPWK -3.3% (downgraded to Neutral from Buy at BTIG Research)
- CRWD -2.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
- LYEL -2.6% (downgraded to Neutral from Overweight at JP Morgan)
- ENR -1% (downgraded to Hold from Buy at Truist)
- ATO -0.7% (downgraded to Equal Weight from Overweight at Wells Fargo)
- LHX -0.7% (downgraded to Mkt Perform from Outperform at Bernstein)